Impaired Cerebellar Development in Mice Overexpressing VGF.


Journal

Neurochemical research
ISSN: 1573-6903
Titre abrégé: Neurochem Res
Pays: United States
ID NLM: 7613461

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 31 07 2018
accepted: 15 11 2018
revised: 09 11 2018
pubmed: 22 11 2018
medline: 8 5 2019
entrez: 22 11 2018
Statut: ppublish

Résumé

VGF nerve growth factor inducible (VGF) is a neuropeptide precursor induced by brain-derived neurotrophic factor and nerve growth factor. VGF is increased in the prefrontal cortex and cerebrospinal fluid in schizophrenia patients. In our previous study, VGF-overexpressing mice exhibited schizophrenia-like behaviors and smaller brain weights. Brain developmental abnormality is one cause of mental illness. Research on brain development is important for discovery of pathogenesis of mental disorders. In the present study, we investigated the role of VGF on cerebellar development. We performed a histological analysis with cerebellar sections of adult and postnatal day 3 mice by Nissl staining. To investigate cerebellar development, we performed immunostaining with antibodies of immature and mature granule cell markers. To understand the mechanism underlying these histological changes, we examined MAPK, Wnt, and sonic hedgehog signaling by Western blot. Finally, we performed rotarod and footprint tests using adult mice to investigate motor function. VGF-overexpressing adult mice exhibited smaller cerebellar sagittal section area. In postnatal day 3 mice, a cerebellar sagittal section area reduction of the whole cerebellum and external granule layer and a decrease in the number of mature granule cells were found in VGF-overexpressing mice. Additionally, the number of proliferative granule cell precursors was lower in VGF-overexpressing mice. Phosphorylation of Trk and Erk1 were increased in the cerebellum of postnatal day 3 VGF-overexpressing mice. Adult VGF-overexpressing mice exhibited motor disability. All together, these findings implicate VGF in the development of cerebellar granule cells via promoting MAPK signaling and motor function in the adult stage.

Identifiants

pubmed: 30460640
doi: 10.1007/s11064-018-2684-7
pii: 10.1007/s11064-018-2684-7
doi:

Substances chimiques

Nerve Growth Factors 0
Neuropeptides 0
Vgf protein, mouse 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

374-387

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 18J14970

Références

J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):193-8
pubmed: 11001597
Development. 2002 Mar;129(6):1435-42
pubmed: 11880352
J Neurochem. 2002 May;81(3):565-74
pubmed: 12065665
Annu Rev Biochem. 2003;72:609-42
pubmed: 12676795
J Neurosci. 2003 Nov 26;23(34):10800-8
pubmed: 14645472
Development. 1992 Sep;116(1):201-11
pubmed: 1483388
Prog Brain Res. 2005;147:319-45
pubmed: 15581715
Cerebellum. 2005;4(4):261-70
pubmed: 16321882
Cerebellum. 2005;4(4):290-4
pubmed: 16321885
Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14584-9
pubmed: 16983076
PLoS Med. 2006 Nov;3(11):e428
pubmed: 17090210
J Neurosci. 2006 Dec 20;26(51):13218-30
pubmed: 17182772
Biochim Biophys Acta. 2007 Aug;1773(8):1299-310
pubmed: 17188374
J Neurosci. 2007 Mar 7;27(10):2472-82
pubmed: 17344385
PLoS One. 2007 Aug 22;2(8):e756
pubmed: 17712404
Nat Med. 2007 Dec;13(12):1476-82
pubmed: 18059283
Science. 2008 Apr 25;320(5875):539-43
pubmed: 18369103
Neuropsychiatr Dis Treat. 2005 Sep;1(3):193-204
pubmed: 18568069
J Neurosci. 2008 Sep 24;28(39):9857-69
pubmed: 18815270
J Vis Exp. 2009 Jan 16;(23):null
pubmed: 19229177
Cell. 2009 Mar 20;136(6):1017-31
pubmed: 19303846
Mol Psychiatry. 2010 Oct;15(10):1023-33
pubmed: 19528963
J Neurosci. 2009 Sep 16;29(37):11550-9
pubmed: 19759302
Development. 2010 Feb;137(3):519-29
pubmed: 20081196
J Neurosci. 2010 Feb 3;30(5):1739-49
pubmed: 20130183
Hum Mol Genet. 2011 Jul 15;20(14):2834-45
pubmed: 21540240
J Neuroimmune Pharmacol. 2012 Sep;7(3):529-32
pubmed: 22570011
J Neurosci. 2012 Oct 31;32(44):15388-402
pubmed: 23115177
Front Neuroanat. 2013 Sep 03;7:29
pubmed: 24027500
Nat Neurosci. 2013 Dec;16(12):1737-44
pubmed: 24141309
PLoS One. 2013 Nov 22;8(11):e81218
pubmed: 24278397
Nat Neurosci. 2014 Jan;17(1):97-105
pubmed: 24292233
PLoS One. 2013 Nov 26;8(11):e81769
pubmed: 24303070
Stem Cell Res. 2014 May;12(3):762-77
pubmed: 24747217
PLoS One. 2014 Jun 12;9(6):e99524
pubmed: 24923991
Nat Commun. 2014 Aug 21;5:4742
pubmed: 25144834
Neuron. 2014 Sep 3;83(5):1131-43
pubmed: 25155956
Development. 2014 Nov;141(21):4031-41
pubmed: 25336734
Genes Dev. 2014 Nov 1;28(21):2407-20
pubmed: 25367036
Dev Biol. 2015 Mar 1;399(1):54-67
pubmed: 25528224
Development. 2015 Feb 1;142(3):522-32
pubmed: 25564653
Dis Model Mech. 2015 Aug 1;8(8):957-67
pubmed: 26035387
J Neurosci. 2015 Jul 15;35(28):10343-56
pubmed: 26180209
Development. 2015 Nov 15;142(22):3921-32
pubmed: 26450969
Science. 2016 Feb 26;351(6276):933-9
pubmed: 26822608
Cell Cycle. 2016;15(2):196-212
pubmed: 26825227
Elife. 2016 Jul 19;5:
pubmed: 27434667
Nature. 2017 Feb 15;542(7641):348-351
pubmed: 28202961
J Neurochem. 2017 Jun 13;:null
pubmed: 28608461
Sci Rep. 2017 Jul 5;7(1):4691
pubmed: 28680036
Pharmacol Rep. 2018 Jun;70(3):476-480
pubmed: 29653412
Science. 1985 Jul 26;229(4711):393-5
pubmed: 3839317
Mol Cell Neurosci. 1995 Apr;6(2):168-83
pubmed: 7551568
J Comp Neurol. 1978 May 1;179(1):23-48
pubmed: 8980716
Neuron. 1997 Aug;19(2):269-81
pubmed: 9292718
Brain Res Mol Brain Res. 1997 Oct 3;49(1-2):307-11
pubmed: 9387894
Eur J Neurosci. 1998 Sep;10(9):3007-11
pubmed: 9758170

Auteurs

Takahiro Mizoguchi (T)

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan.

Masamitsu Shimazawa (M)

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan.

Kazuki Ohuchi (K)

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan.

Yoshiki Kuse (Y)

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan.

Shinsuke Nakamura (S)

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan.

Hideaki Hara (H)

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan. hidehara@gifu-pu.ac.jp.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH